- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Tesh Khullar Highlights Changes That Will Impact Reimbursement for Biosimilars
Tesh Khullar, senior vice president & advisor, Flatiron Health, outlines changes that could impact community oncologists when it comes to reimbursement for biosimilars.
Tesh Khullar, senior vice president & advisor, Flatiron Health, outlines changes that could impact community oncologists when it comes to reimbursement for biosimilars.
Transcript
What are some policy changes that could impact community oncologists in terms of reimbursement for biosimilars?
What we’re seeing, and Amgen was the first one to do it, they went right to the payer. They went right to UnitedHealthcare and made sure not only branded Neulasta but their biosimialrs are a preferred therapy for UnitedHealthcare, which then dictated down to practices needing to utilize it for UnitedHealthcare patients. So, what you’re going to see, in my opinion, are biosimilars going to manufacturers, getting them on the formulary. It’s actually going to be a problem for community oncology. From a financial perspective it’s going to be an opportunity, but the logistical problems of having the brand of biosimilar different by payer is going to be an operational nightmare to manage.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
